MetaCap

Who Owns Kailera Therapeutics Stock?

NASDAQ: KLRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

11.02-0.56 (-4.84%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
93.65%
Institutional holders
177
  • Institutions 90.7%
  • Insiders 9.3%
  • Public and other 0.0%

Who owns Kailera Therapeutics stock?

Institutional investors own about 93.6% of Kailera Therapeutics's shares, spread across 177 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 9.25% of KLRA.

The largest institutional holders are Bain Capital Investors Llc (20.22%), Bain Capital Life Sciences Investors, LLC (17.39%) and RTW Investments LP (8.30%). Together, the top 10 institutions control 70.3% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their KLRA positions and 0 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of KLRA

Kailera Therapeutics top institutional holders
InstitutionShares% HeldChange
Bain Capital Investors Llc26.26M20.22%+100.0%
Bain Capital Life Sciences Investors, LLC22.58M17.39%+100.0%
RTW Investments LP10.78M8.30%+100.0%
Canada Pension Plan Investment Board7.30M5.63%+100.0%
Atlas Venture Life Science Advisors, LLC 5.17M3.98%0.0%
FMR, LLC4.66M3.59%+17.4%
Blackrock Inc.4.57M3.52%+16.4%
Price (T.Rowe) Associates Inc3.53M2.72%+100.0%
Citadel Advisors Llc3.24M2.50%+100.0%
Adage Capital Partners GP L.L.C.3.21M2.47%+100.0%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of KLRA

Kailera Therapeutics top fund holders
FundShares% Held
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund2.19M1.69%
Fidelity Select Portfolios-Select Biotechnology Portfolio1.66M1.28%
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF1.22M0.94%
iShares Trust-iShares Russell 2000 ETF1.20M0.92%
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.18M0.91%
T. Rowe Price Health Sciences Fund, Inc.904.28K0.70%
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund850.04K0.65%
Columbia Funds Series Trust I-Columbia Small Cap Growth Fund784.06K0.60%
BlackRock Funds-BlackRock Health Sciences Opportunities Portfolio761.69K0.59%
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund700.90K0.54%

Frequently asked questions

Who is the largest shareholder of Kailera Therapeutics?

Bain Capital Investors Llc is the largest institutional shareholder of KLRA, owning 20.22% of shares outstanding (26.26M shares) as of its latest 13F filing.

What percentage of Kailera Therapeutics is owned by institutions?

Institutions own about 93.6% of KLRA shares and 103.2% of the public float.

How much of Kailera Therapeutics do insiders own?

Insiders, such as officers and directors, own about 9.25% of KLRA shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related